Basilea Pharmaceutica AG (id:13109 BSLN)
40.55 CHF
Opening hours: 09:00 - 17:20 (Central European Standard Time: 11/22/2024 2:01:29 AM)
Exchange closed, opens in 6 hours 58 minutes
About Basilea Pharmaceutica AG
Market Capitalization 482.42M
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union. It also offers medicine drug for invasive fungal infections. In addition, the company provides Zevtera, an antibiotic for the treatment of community and hospital-acquired pneumonia, as well as offers treatment of acute bacterial skin and skin structure infections, and Staphylococcus aureus bacteremia. Further, it offers Fosmanogepix, an antifungal drug for the treatment of Candidemia which in Phase II clinical trials. Basilea Pharmaceutica AG was founded in 2000 and is headquartered in Allschwil, Switzerland.
| Headquarters (address) |
Hegenheimermattweg 167b Allschwil 4123 Switzerland |
| Phone | 41 61 606 11 11 |
| Website | https://www.basilea.com |
| Employees | 156 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | BSLN |
| Exchange | Swiss Stock Exchange |
| Currency | CHF |
| 52 week range | 32.00 - 47.95 |
| Market Capitalization | 482.42M |
| Dividend yield forward | 50.31 % |
| Dividend yield forward Switzerland (ID:153, base:169) | 13.52 % |
| P/E trailing | 53.08 |
| P/E forward | 11.12 |
| Price/Sale | 3.24 |
| Price/Book | 28.74 |
| Beta | 0.739 |
| EPS | -0.070 |
| EPS Switzerland (ID:153, base:185) | 29.31 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Basilea Pharmaceutica AG has raised their dividend 50.31 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Basilea Pharmaceutica AG has raised their dividend 50.31 years in a row. This is below the 41125.084400 year average in the 'Biotechnology' industry